Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis

<div>Sensitivity analyses of the impact of ALRI on the survival time among individuals with liver cancer. (a). Overall survival and (b) progression-free survival.</div>

Disease Markers

fig3

Figure 3

Figure 3: Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis 

Figure 3 | Prognostic and Clinical Significance of Aspartate Aminotransferase-to-Lymphocyte Ratio Index in Individuals with Liver Cancer: A Meta-Analysis 